Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-08-21 BAKER BROS. ADVISORS LP Director Purchase · Series C Preferred Stock +75,873 $14.52 $1.1M 75,873
2020-08-21 BAKER BROS. ADVISORS LP Director Purchase · Series C Preferred Stock +957,211 $14.52 $13.9M 957,211
2020-08-21 ORBIMED ADVISORS LLC Director Purchase · Series C Preferred Stock +1,033,084 1,033,084
2020-08-21 Bonita David P Director Purchase · Series C Preferred Stock +1,033,084 1,033,084
2020-03-27 BAKER BROS. ADVISORS LP Director Purchase · Series B Preferred Stock +308,793 $3.93 $1.2M 308,793
2020-03-27 BAKER BROS. ADVISORS LP Director Purchase · Series B Preferred Stock +3,373,029 $3.93 $13.3M 3,373,029
2020-03-27 ORBIMED ADVISORS LLC Director Purchase · Series B Preferred Stock +3,681,822 7,363,644
2020-03-27 FRIEDMAN PAUL A Director Purchase · Series B Preferred Stock +76,288 152,576
2020-03-27 Bonita David P Director Purchase · Series B Preferred Stock +3,681,822 7,363,644

Page 19 of 19 · 369 trades